These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27418364)
1. Neurological deterioration in the treatment of Herpes zoster: encephalitis or neurotoxic effect of acyclovir? De Cauwer H; Maes J; Viaene M; Janssen L; Belmans L Acta Neurol Belg; 2017 Mar; 117(1):395-397. PubMed ID: 27418364 [No Abstract] [Full Text] [Related]
2. More about acyclovir neurotoxicity in patients on haemodialysis. Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F Nephron; 1998; 78(2):228-9. PubMed ID: 9496746 [No Abstract] [Full Text] [Related]
3. Severe acyclovir-induced encephalopathy in an elderly patient with herpes zoster. Nakajima K; Momo K; Nimura S; Kaizaki-Mitsumoto A; Kanazawa N; Inaba T; Saito T; Wada Y; Honda H; Numazawa S; Sasaki T Eur J Clin Pharmacol; 2022 Mar; 78(3):527-529. PubMed ID: 34714374 [No Abstract] [Full Text] [Related]
4. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster. Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281 [No Abstract] [Full Text] [Related]
6. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter. Kageyama R; Hashizume H J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129 [No Abstract] [Full Text] [Related]
7. [Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir]. Braun JS; Apel I; Schäffer S; Schumacher M; Berger M Nervenarzt; 1998 Nov; 69(11):1015-8. PubMed ID: 9859124 [TBL] [Abstract][Full Text] [Related]
8. Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudin. Aksoy B; Altaykan-Hapa A; Cengiz A; Mete Aksoy H; Atakan N Eur J Dermatol; 2010; 20(2):247-8. PubMed ID: 20103497 [No Abstract] [Full Text] [Related]
9. Emergent hemodialysis for acyclovir toxicity. Hsu CC; Lai TI; Lien WC; Chen WJ; Fang CC Am J Emerg Med; 2005 Nov; 23(7):899-900. PubMed ID: 16291450 [No Abstract] [Full Text] [Related]
11. Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairment. Brady M; Main J Clin Med (Lond); 2009 Dec; 9(6):630. PubMed ID: 20095318 [No Abstract] [Full Text] [Related]
13. Acyclovir and neurologic manifestations. Auwerx J; Knockaert D; Hofkens P Ann Intern Med; 1983 Dec; 99(6):882-3. PubMed ID: 6651045 [No Abstract] [Full Text] [Related]
14. [A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster]. Matsumoto R; Yoshida T; Tabata K; Nakagawa S; Yanagisawa N Rinsho Shinkeigaku; 1996 Apr; 36(4):590-3. PubMed ID: 8810856 [TBL] [Abstract][Full Text] [Related]
15. [On the mailing list: use of acyclovir in patients on hemodialysis]. D'Amico M; Fraticelli M; Limido A G Ital Nefrol; 2005; 22(1):66-9. PubMed ID: 15786379 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487 [TBL] [Abstract][Full Text] [Related]
17. Coma secondary to aciclovir neurotoxicity. Loughrey J; Coleman P; Donohue J; Marsh B Ir J Med Sci; 2001; 170(1):69-70. PubMed ID: 11440418 [No Abstract] [Full Text] [Related]
18. [Acyclovir nephrotoxicity]. Briso-Montiano JM; Hernández E; Escudero E; Mendiluce A; Sánchez L; Miyar V An Med Interna; 1995 Oct; 12(10):501-2. PubMed ID: 8519942 [TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome. Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885 [TBL] [Abstract][Full Text] [Related]
20. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older. Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]